Just 13 health information exchanges (HIEs) out of an available 100 have been evaluated by examining usage information, making it hard to draw conclusions about their impact.
Just 13 health information exchanges (HIEs) out of an available 100 have been evaluated by examining usage information, according to a new review by the RAND Corporation.
“There are likely other health information exchange organizations in the country that are being used, and some may be having an impact. But, if they exist, they haven't been evaluated,” said Robert Rudin, lead author of the study and an associate policy researcher at RAND, a nonprofit research organization. “And without an evaluation, it is difficult to draw conclusions.”
Researchers evaluated existing HIE literature for effects on health outcomes, cost measures, and patient and provider attitudes toward health exchanges. They were unable to find evidence as to whether or not health information exchanges can help solve the problem of fragmented health care, according to the review.
“We really don't know what works and what doesn't when it comes to implementing health information exchanges,” Rudin said. “The evidence base is small relative to the size of federal and state investments, and relative to expectations that it will help address issues related to fragmentation of care.”
READ: Health information exchanges get down to business
Of the HIEs that were studied, there is some evidence that they reduced emergency department costs, but the review notes that other outcomes are unknown.
HIEs are supposed to facilitate the sharing of patients’ medical information across a chain of providers and stakeholders, leading to lowered costs and improvements in care. They’re being heavily promoted by the U.S. government, which has provided nearly $600 million to statewide HIEs in the last few years, according to Rand.
But as that initial federal money dries up, some HIEs are charging access fees. The review of 17 studies relating to sustainability found that just 25% of HIEs consider themselves financially stable.
Those fees have caused pushback in the industry, though. According to the most recent Black Book survey, 86% of payers object to the annual fees charged by HIEs.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen